Document is current
Any future updates will be listed below
-
Authors
Gefen, Ashley M.
Sethna, Christine B.
Cil, Onur
Perwad, Farzana
Schoettler, Megan
Michael, Mini
Angelo, Joseph R.
Safdar, Adnan
Amlie-Wolf, Louise
Hunley, Tracy E.
Ellison, Jonathan S.
Feig, Daniel
Zaritsky, Joshua
- License Information
-
More Information
Article History
Received: 12 October 2022
Revised: 2 January 2023
Accepted: 2 January 2023
First Online: 23 January 2023
Declarations
:
: This study protocol was reviewed and approved by the Northwell Institutional Review Board (IRB #20–0686). Written informed consent was not required from participants as the study was exempt.
: Alnylam Pharmaceuticals sponsored the program that paid for the genetic testing of the cohort. Ashley M. Gefen has received research support from Natera, Inc. Jonathan S. Ellison is a consultant for Alnylam Pharmaceuticals and contributes to UpToDate. Christine Sethna was on an advisory board for Trevere Therapeutics. No other authors have a conflict of interest.
